OVATION SCIENCE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.03 CAD | 0.00% |
|
-33.33% | -14.29% |
| 29/05 | Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 07/05 | Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6.946 | 4.647 | 10.43 | 1.762 | 0.7344 | 1.186 |
| Enterprise Value (EV) 1 | 5.254 | 3.897 | 8.89 | 1.115 | 0.7466 | 1.33 |
| P/E ratio | -9.51 x | -3.87 x | -7.99 x | -0.74 x | -0.92 x | -1.31 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 72 x | 15.4 x | 13.9 x | 7.84 x | 5.32 x | 19.2 x |
| EV / Revenue | 54.5 x | 12.9 x | 11.9 x | 4.96 x | 5.4 x | 21.5 x |
| EV / EBITDA | - | -46,73,545 x | -95,09,622 x | -7,35,205 x | -10,10,722 x | -17,40,923 x |
| EV / FCF | -31.5 x | -5.73 x | -8.64 x | -6.08 x | -2.22 x | -56.1 x |
| FCF Yield | -3.18% | -17.5% | -11.6% | -16.5% | -45.1% | -1.78% |
| Price to Book | 3.17 x | 3.14 x | 3.35 x | 2.5 x | -8.86 x | -1.82 x |
| Nbr of stocks (in thousands) | 23,153 | 23,235 | 29,375 | 29,375 | 29,375 | 33,895 |
| Reference price 2 | 0.3000 | 0.2000 | 0.3550 | 0.0600 | 0.0250 | 0.0350 |
| Announcement Date | 30/04/19 | 29/04/20 | 30/04/21 | 02/05/22 | 01/05/23 | 07/05/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.0964 | 0.3024 | 0.75 | 0.2249 | 0.1382 | 0.0619 |
| EBITDA | - | -0.8339 | -0.9348 | -1.516 | -0.7387 | -0.764 |
| EBIT 1 | -0.4127 | -0.8365 | -0.9434 | -1.525 | -0.7454 | -0.7672 |
| Operating Margin | -428.09% | -276.63% | -125.79% | -677.71% | -539.55% | -1,238.82% |
| Earnings before Tax (EBT) 1 | -0.5084 | -0.8359 | -1.185 | -2.394 | -0.7941 | -0.8131 |
| Net income 1 | -0.5084 | -0.8359 | -1.185 | -2.394 | -0.7941 | -0.8131 |
| Net margin | -527.35% | -276.45% | -157.98% | -1,064.14% | -574.76% | -1,312.93% |
| EPS 2 | -0.0315 | -0.0517 | -0.0444 | -0.0815 | -0.0270 | -0.0268 |
| Free Cash Flow 1 | -0.167 | -0.6805 | -1.029 | -0.1834 | -0.3364 | -0.0237 |
| FCF margin | -173.26% | -225.05% | -137.16% | -81.55% | -243.51% | -38.26% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 30/04/19 | 29/04/20 | 30/04/21 | 02/05/22 | 01/05/23 | 07/05/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 0.01 | 0.14 |
| Net Cash position 1 | 1.69 | 0.75 | 1.54 | 0.65 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.0166 x | -0.1882 x |
| Free Cash Flow 1 | -0.17 | -0.68 | -1.03 | -0.18 | -0.34 | -0.02 |
| ROE (net income / shareholders' equity) | -36.9% | -45.6% | -51.7% | -126% | -255% | 221% |
| ROA (Net income/ Total Assets) | -14.2% | -22.9% | -23.2% | -47.4% | -107% | -528% |
| Assets 1 | 3.572 | 3.65 | 5.116 | 5.052 | 0.7455 | 0.1541 |
| Book Value Per Share 2 | 0.0900 | 0.0600 | 0.1100 | 0.0200 | -0 | -0.0200 |
| Cash Flow per Share 2 | 0.0200 | 0.0200 | 0.0100 | 0.0200 | 0 | 0 |
| Capex | - | 0.03 | - | - | - | - |
| Capex / Sales | - | 10.47% | - | - | - | - |
| Announcement Date | 30/04/19 | 29/04/20 | 30/04/21 | 02/05/22 | 01/05/23 | 07/05/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -14.29% | 772K | |
| -22.92% | 985M | |
| -14.04% | 134M | |
| -21.75% | 57.16M | |
| +2.03% | 57.07M |
- Stock Market
- Equities
- OVAT Stock
- Financials Ovation Science Inc.
